Miae Oh, MD
Allergy & Immunology · Allentown, PANPI 1740455013
Payments from drug & device makers
Across 525 payments — averaging $36.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$4K
- Sanofi$3K
- AstraZeneca$3K
- CSL Behring$2K
- GSK$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- plus $5K from 34 others
What the payments were for
- Consulting fees$2,53213%
- Food & beverage$15,81384%
- Education$5543%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 40 | $3,651 |
| Sanofi | 83 | $3,206 |
| AstraZeneca | 98 | $2,869 |
| CSL Behring | 46 | $1,840 |
| GSK | 47 | $1,297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $1,236 |
| Amgen | 22 | $742 |
| Optinose US, Inc. | 24 | $615 |
| Biocryst US Sales Co., LLC | 14 | $483 |
| Pfizer | 18 | $399 |
| Pharming Healthcare, Inc. | 5 | $355 |
| Grifols USA, LLC | 13 | $275 |
| Genentech USA, Inc. | 6 | $190 |
| Sanofi-aventis U.S. LLC | 3 | $181 |
| Aimmune Therapeutics, Inc. | 8 | $165 |
| Ionis Pharmaceuticals, Inc. | 2 | $157 |
| Blueprint Medicines Corporation | 3 | $157 |
| Novartis | 7 | $140 |
| Kaleo, Inc. | 8 | $111 |
| Phathom Pharmaceuticals, Inc. | 5 | $105 |
| Alk-abello, Inc | 6 | $92 |
| Phadia US Inc. | 4 | $72 |
| Organogenesis Inc. | 2 | $60 |
| Stryker | 2 | $56 |
| Paratek Pharmaceuticals, Inc. | 2 | $53 |
| Covis Pharma GmbH | 2 | $44 |
| Boehringer Ingelheim | 2 | $39 |
| Acclarent, Inc | 1 | $38 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| Shire North American Group Inc | 2 | $32 |
| Incyte Corporation | 1 | $28 |
| Bio Products Laboratory USA, Inc. | 2 | $28 |
| Merck | 2 | $27 |
| Intersect ENT, Inc. | 1 | $27 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Axogen | 1 | $13 |
| Organon | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,899 in reported general payments places this provider in the 80th percentile of 175 allergy & immunology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 26 | $137,553 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $9,313 |
| Advair HfaFluticasone Propion/Salmeterol | 14 | $6,814 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 49 | $6,048 |
| Epinephrine | 26 | $4,573 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $3,682 |
| Arnuity ElliptaFluticasone Furoate | 17 | $3,672 |
| Azelastine Hcl | 117 | $2,850 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,470 |
| Mometasone Furoate | 20 | $1,581 |
| Fluticasone Propionate | 76 | $1,338 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $640 |
| Levocetirizine Dihydrochloride | 62 | $556 |
| Ipratropium Bromide | 11 | $405 |
| Famotidine | 16 | $127 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $1,840 | $137,55326 claims |
| GSKBreo Ellipta, Arnuity Ellipta | $1,297 | $12,98537 claims |
| Hikma Pharmaceuticals USAEpinephrine | $17 | $4,57326 claims |
| AstraZenecaSymbicort | $2,869 | $2,47011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 175 allergy & immunology providers in Pennsylvania.
Other allergy & immunology in Allentown
- Robert ZembleAllentown$14K
- Drew WeissmanPhiladelphia$15.3M
- Timothy CraigHershey$2M
- Eric SchenkelBethlehem$845K
- Sergei BelenkyPittsburgh$775K
- Sandra GawchikUpland$390K
- Anthony RooklinGlen Mills$319K
- Corinna BowserNarberth$229K
- Thomas KleinHavertown$222K
- Rahul DattaPhiladelphia$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.